Scarica l'app Stockscreener
1.07
2.73%
-0.03
Dopo l'orario di chiusura:
1.02
-0.05
-4.67%
Precedente Chiudi:
$1.10
Aprire:
$1.13
Volume 24 ore:
749.27K
Relative Volume:
2.66
Capitalizzazione di mercato:
$135.15M
Reddito:
-
Utile/perdita netta:
$-70.78M
Rapporto P/E:
-1.9107
EPS:
-0.56
Flusso di cassa netto:
$-61.27M
1 W Prestazione:
+18.89%
1M Prestazione:
+42.61%
6M Prestazione:
+47.93%
1 anno Prestazione:
-63.85%
Intervallo 1D:
$1.03
$1.24
Intervallo di 1 settimana:
$0.8197
$1.24
Portata 52W:
$0.62
$2.99
Nautilus Biotechnology Inc Stock (NAUT) Company Profile
Nome
Nautilus Biotechnology Inc
Settore
Industria
Telefono
206-333-2001
Indirizzo
2701 EASTLAKE AVE EAST, SEATTLE
Confronta NAUT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NAUT
Nautilus Biotechnology Inc
|
1.07 | 118.79M | 0 | -70.78M | -61.27M | -0.56 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Nautilus Biotechnology Inc Stock (NAUT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-05 | Downgrade | Goldman | Neutral → Sell |
| 2024-06-27 | Iniziato | Guggenheim | Buy |
| 2024-06-03 | Ripresa | Jefferies | Hold |
| 2022-01-06 | Iniziato | Morgan Stanley | Equal-Weight |
| 2021-11-02 | Iniziato | Cowen | Outperform |
| 2021-08-04 | Iniziato | Goldman | Neutral |
| 2021-07-13 | Iniziato | Jefferies | Buy |
Mostra tutto
Nautilus Biotechnology Inc Borsa (NAUT) Ultime notizie
Strategies to average down on Nautilus Biotechnology Inc.Weekly Trade Analysis & Consistent Income Trade Recommendations - newser.com
How Nautilus Biotechnology Inc. stock performs in rate cut cycles2025 Institutional Moves & Fast Exit and Entry Strategy Plans - newser.com
How to recover losses in Nautilus Biotechnology Inc. stockOil Prices & Fast Exit/Entry Strategy Plans - newser.com
Earnings visualization tools for Nautilus Biotechnology Inc.Quarterly Market Review & High Return Trade Opportunity Guides - newser.com
Will Nautilus Biotechnology Inc. stock outperform value stocksJuly 2025 Weekly Recap & Stepwise Entry/Exit Trade Alerts - newser.com
Why Nautilus Biotechnology Inc. stock is recommended by analystsRate Hike & AI Driven Stock Reports - newser.com
Nautilus Biotechnology Inc.’s volatility index tracking explainedEarnings Growth Report & Reliable Volume Spike Trade Alerts - newser.com
Can Nautilus Biotechnology Inc. stock weather global recessionJobs Report & Precise Swing Trade Alerts - newser.com
Published on: 2025-10-13 09:25:11 - newser.com
Weiss Ratings Reaffirms Sell (D-) Rating for Nautilus Biotechnology (NASDAQ:NAUT) - MarketBeat
Will Nautilus Biotechnology Inc. price bounce be sustainableJuly 2025 Fed Impact & Accurate Buy Signal Notifications - newser.com
Should you hold or exit Nautilus Biotechnology Inc. now2025 Analyst Calls & Low Volatility Stock Suggestions - newser.com
Live market analysis of Nautilus Biotechnology Inc.Market Trend Review & Reliable Entry Point Alerts - newser.com
Published on: 2025-10-09 04:18:13 - newser.com
Will Nautilus Biotechnology Inc. see short term momentumFed Meeting & Reliable Price Action Trade Plans - newser.com
Is Nautilus Biotechnology Inc a good long term investmentMarket Entry Points & Smart Beta Strategies That Actually Work - earlytimes.in
Nautilus Biotechnology to Announce Third Quarter 2025 Financial Results on October 28, 2025 - GlobeNewswire
Nautilus Biotechnology, Inc. to Announce Third Quarter 2025 Financial Results on October 28, 2025 - Quiver Quantitative
Nautilus Biotechnology to Participate in Upcoming September Investor Conferences - 富途牛牛
What institutional flow reveals about Nautilus Biotechnology Inc.2025 Institutional Moves & Community Consensus Picks - newser.com
Nautilus Biotechnology Inc. recovery potential after sell offJuly 2025 Fed Impact & Free Community Supported Trade Ideas - newser.com
Is now a turning point for Nautilus Biotechnology Inc.July 2025 Catalysts & High Accuracy Swing Trade Signals - newser.com
How sentiment analysis helps forecast Nautilus Biotechnology Inc.Weekly Stock Summary & Verified Entry Point Signals - newser.com
Nautilus Biotechnology Inc. stock daily chart insightsWeekly Profit Summary & Long Hold Capital Preservation Tips - newser.com
Detecting price anomalies in Nautilus Biotechnology Inc. with AI2025 Top Gainers & Fast Gaining Stock Reports - newser.com
Analyzing Nautilus Biotechnology Inc. with multi timeframe chartsJuly 2025 Opening Moves & Intraday High Probability Alerts - newser.com
Nautilus Biotechnology Inc Azioni (NAUT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Nautilus Biotechnology Inc Azioni (NAUT) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Patel Sujal M | CEO, President, and Secretary |
Sep 08 '25 |
Buy |
0.68 |
83,500 |
57,031 |
10,341,721 |
| Murphy Matthew B. | General Counsel |
Sep 04 '25 |
Buy |
0.64 |
20,000 |
12,858 |
74,140 |
| Mowry Anna | CFO and Treasurer |
May 29 '25 |
Buy |
0.77 |
15,000 |
11,488 |
83,000 |
| Mallick Parag | Chief Scientist |
May 08 '25 |
Buy |
0.73 |
12,000 |
8,788 |
20,491,892 |
| Mallick Parag | Chief Scientist |
May 12 '25 |
Buy |
0.73 |
1,500 |
1,098 |
20,493,392 |
| Patel Sujal M | CEO, President, and Secretary |
Mar 19 '25 |
Buy |
0.99 |
53,300 |
53,028 |
10,117,788 |
| Patel Sujal M | CEO, President, and Secretary |
Mar 20 '25 |
Buy |
1.00 |
23,933 |
23,890 |
10,141,721 |
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):